Advertisement

Molecular Diagnosis & Therapy

, Volume 14, Issue 2, pp 113–117 | Cite as

A Case of a Novel PML/RARA Short Fusion Transcript with Truncated Transcription Variant 2 of the RARA Gene

  • Ivana Jezíšková
  • Filip Rázga
  • Jana Gazdová
  • Michael Doubek
  • Tomáš Jurček
  • Zdeněk Kořístek
  • Jiří Mayer
  • Dana Dvořáková
Case Report

Abstract

Acute promyelocytic leukemia (APL) with atypical breakpoints in the promyelocytic leukemia (PML) and retinoic acid receptor-α (RARA) genes represents a rare leukemic event, which occurs preferentially in patients with variant types of the PML/RARA fusion gene. Here we report on a patient with APL with a unique PML/RARA fusion transcript that harbors a short type of this fusion gene, exhibiting unexpected results of standard PCR diagnostics. The detected transcript originates from fusion of PML exon 4 and a truncated form of transcription variant 2 of the RARA gene, with an additional 9 bp insertion. According to our knowledge, this differs from all previously described fusion transcripts.

Keywords

Fusion Gene Acute Promyelocytic Leukemia Fusion Transcript Acute Promyelocytic Leukemia Patient RARA Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by research grant no. MSM0021622430 from the Ministry of Education, Youth and Sports, Prague, Czech Republic. The authors have no conflicts of interest that are directly relevant to the content of this study.

References

  1. 1.
    Slack JL, Willman CL, Andersen JW, et al. Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARα isoform: results from Intergroup protocol 0129. Blood 2000; 95(2): 398–403PubMedGoogle Scholar
  2. 2.
    Biondi A, Rambaldi A, Pandolfi PP, et al. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80(2): 492–7PubMedGoogle Scholar
  3. 3.
    Grimwade D, Gorman P, Duprez E, et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 1997; 90(12): 4876–85PubMedGoogle Scholar
  4. 4.
    Grimwade D, Jovanovic JV, Hills RK, et al. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. J Clin Oncol 2009; 27(22): 3650–8PubMedCrossRefGoogle Scholar
  5. 5.
    Gabert J, Beillard E, van der Velden VHJ, et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia — a Europe Against Cancer program. Leukemia 2003; 17: 2318–57PubMedCrossRefGoogle Scholar
  6. 6.
    Gu BW, Xiong H, Zhou Y, et al. Variant-type PML/RARα fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RARα gene and identification of a new clinical subtype resistant to retinoic acid therapy. Proc Natl Acad Sci U S A 2002; 99(11): 7640–5PubMedCrossRefGoogle Scholar
  7. 7.
    Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: AIRC Press, 2008Google Scholar
  8. 8.
    Catalano A, Dawson MA, Somana K, et al. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia. Blood 2007; 110(12): 4072–6CrossRefGoogle Scholar
  9. 9.
    Pandolfi PP, Alcalay M, Fagioli M, et al. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J 1992; 11(4): 1397–407PubMedGoogle Scholar
  10. 10.
    Ismail S, Ababneh N, Awidi A. Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia. Acta Haematol 2007; 118: 183–7PubMedCrossRefGoogle Scholar
  11. 11.
    Barragan E, Bolufer P, Martin G, et al. Identification of two atypical PML-RARα transcripts in two patients with acute promyelocytic leukemia. Leuk Res 2002; 26(5): 439–42PubMedCrossRefGoogle Scholar
  12. 12.
    Park TS, Kim JS, Song J, et al. Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis. Cancer Genet Cytogenet 2009; 188(2): 103–7PubMedCrossRefGoogle Scholar
  13. 13.
    Vizmanos JL, Larráyoz MJ, Odero MD, et al. Two new molecular PML-RARα variants: implications for the molecular diagnosis of APL. Haematologica 2002; 87(08): ELT37PubMedGoogle Scholar
  14. 14.
    Lafage-Pochitaloff M, Alcalay M, Brunel V, et al. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes. Blood 1995; 85: 1169–74PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Ivana Jezíšková
    • 1
  • Filip Rázga
    • 1
  • Jana Gazdová
    • 1
  • Michael Doubek
    • 2
  • Tomáš Jurček
    • 1
  • Zdeněk Kořístek
    • 2
  • Jiří Mayer
    • 2
  • Dana Dvořáková
    • 1
  1. 1.Center of Molecular Biology and Gene Therapy, Department of Internal Medicine—Hemato-oncologyUniversity Hospital Brno and Masaryk UniversityBrnoCzech Republic
  2. 2.Department of Internal Medicine—Hemato-oncologyUniversity Hospital Brno and Masaryk UniversityBrnoCzech Republic

Personalised recommendations